155 related articles for article (PubMed ID: 3092388)
1. Fibrinolytic activity and protein C in preeclampsia.
Aznar J; Gilabert J; Estellés A; España F
Thromb Haemost; 1986 Jun; 55(3):314-7. PubMed ID: 3092388
[TBL] [Abstract][Full Text] [Related]
2. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
[TBL] [Abstract][Full Text] [Related]
3. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
4. Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia.
Gilabert J; Estellés A; Aznar J; España F; Andrés C; Santos T; Vallés J
Thromb Haemost; 1990 Jun; 63(3):361-6. PubMed ID: 2144918
[TBL] [Abstract][Full Text] [Related]
5. The fast inhibitor of tissue plasminogen activator in plasma during pregnancy.
Wiman B; Csemiczky G; Marsk L; Robbe H
Thromb Haemost; 1984 Oct; 52(2):124-6. PubMed ID: 6441300
[TBL] [Abstract][Full Text] [Related]
6. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
Páramo JA; Alfaro MJ; Rocha E
Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269
[TBL] [Abstract][Full Text] [Related]
7. [Endothelial damage and blood coagulation activation in preeclampsia].
Stella A; Babbo GL; Grella PV
Minerva Ginecol; 1998 Nov; 50(11):463-8. PubMed ID: 9882986
[TBL] [Abstract][Full Text] [Related]
8. [Thromboembolic disease and anomalies of fibrinolysis].
Juhan-Vague I; Aillaud MF; Valadier J; Alessi MC; Serradimigni A
Ann Med Interne (Paris); 1986; 137(6):471-4. PubMed ID: 3101564
[TBL] [Abstract][Full Text] [Related]
9. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
Kluft C; Jie AF; Rijken DC; Verheijen JH
Thromb Haemost; 1988 Apr; 59(2):329-32. PubMed ID: 3133814
[TBL] [Abstract][Full Text] [Related]
10. Placental-type plasminogen activator inhibitor in preeclampsia.
de Boer K; Lecander I; ten Cate JW; Borm JJ; Treffers PE
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 1):518-22. PubMed ID: 3126658
[TBL] [Abstract][Full Text] [Related]
11. [Changes of fibrinolysis during labour with and without aprotinin application].
Kühnert M; Stein W; Tekesin I; Hellmeyer L; Schmidt S
Z Geburtshilfe Neonatol; 2003; 207(3):90-100. PubMed ID: 12891467
[TBL] [Abstract][Full Text] [Related]
12. Studies of fibrinolytic activity of uremic and longterm hemodialytic patients with special reference to fibrinolytic inhibitor.
Homma T; Ichikawa T
Biochem Exp Biol; 1979; 15(3):229-36. PubMed ID: 122165
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor activity in bacterial infection.
Páramo JA; Fernández Diaz FJ; Rocha E
Thromb Haemost; 1988 Jun; 59(3):451-4. PubMed ID: 3142082
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia.
Estellés A; Gilabert J; España F; Aznar J; Galbis M
Am J Obstet Gynecol; 1991 Jul; 165(1):138-42. PubMed ID: 1906680
[TBL] [Abstract][Full Text] [Related]
15. [Differentiation of a normal population and of a cohort of patients presenting with a history of idiopathic thromboembolism as identified with fibrinolytic tests].
Nicoloso G; Hauert J; Kruithof EK; van Melle G; Bachmann F
Schweiz Med Wochenschr; 1988 Jan; 118(4):122-4. PubMed ID: 3125604
[TBL] [Abstract][Full Text] [Related]
16. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.
Auwerx J; Bouillon R; Collen D; Geboers J
Arteriosclerosis; 1988; 8(1):68-72. PubMed ID: 2449156
[TBL] [Abstract][Full Text] [Related]
17. Hemostasis in hypertensive disorders of pregnancy.
Saleh AA; Bottoms SF; Norman G; Farag A; Mammen EF
Obstet Gynecol; 1988 May; 71(5):719-22. PubMed ID: 2451798
[TBL] [Abstract][Full Text] [Related]
18. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F
Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741
[TBL] [Abstract][Full Text] [Related]
19. Plasma fibrinolytic activity in patients undergoing major abdominal surgery.
Mellbring G; Dahlgren S; Wiman B
Acta Chir Scand; 1985; 151(2):109-14. PubMed ID: 3873768
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
